Clinical Trial: Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma
Study Status: Completed
Recruit Status: RECRUITING
Condition: High-grade Glioma
Study Type: INTERVENTIONAL
Official Title: A Phase 1b Open-Label Study Investigating the Tolerability, Safety, and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma
Brief Summary:
This is a phase 1 open-label, multicenter study to investigate tolerability, safety and PK properties of oral OKN-007 in patients with recurrent high-grade glioma.
Read more